Stockholm3 - A new option to detect Prostate Cancer Authors Moosa Zulfiqar Ali Medical College, Combined Military Hospital, Lahore, Pakistan Roshaan Ahmad Medical College, Combined Military Hospital, Lahore, Pakistan Amna Akmal Medical College, Combined Military Hospital, Lahore, Pakistan DOI: https://doi.org/10.47391/JPMA.5109 Abstract Prostate cancer is the second most often diagnosed cancer and the sixth most prevalent cause of cancer mortality in males globally.1 It is usually screened by measuring prostate specific antigen (PSA) levels in the blood. However, the PSA test results in unnecessary biopsies, over-diagnosis, over-treatment, and higher expenses.2 The Karolinska Institutet in Stockholm, Sweden, developed the Stockholm3 test to overcome PSA test’s shortcomings. ---Continue Downloads Full Text Article Published 2022-04-05 How to Cite Ali, M. Z. ., Ahmad, R., & Akmal, A. (2022). Stockholm3 - A new option to detect Prostate Cancer. Journal of the Pakistan Medical Association, 72(4), 784–784. https://doi.org/10.47391/JPMA.5109 More Citation Formats ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver Download Citation Endnote/Zotero/Mendeley (RIS) BibTeX Issue Vol. 72 No. 4 (2022): APRIL Section Letter to the Editor